(Q39477768)

12 September 2017

Targeting intracellular oncoproteins with antibody therapy or vaccination (English)

1 reference

12 September 2017

1 reference

Ke Guo

1

1 reference

12 September 2017

Jie Li

2

1 reference

12 September 2017

Jing Ping Tang

3

1 reference

12 September 2017

Cheng Peow Bobby Tan

4

1 reference

12 September 2017

Cheng William Hong

5

1 reference

12 September 2017

Abdul Qader O Al-Aidaroos

6

1 reference

12 September 2017

Leyon Varghese

7

1 reference

12 September 2017

Caixia Huang

8

1 reference

12 September 2017

Qi Zeng

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

Science Translational Medicine

12 September 2017

1 reference

12 September 2017

3

1 reference

12 September 2017

99

1 reference

12 September 2017

99ra85

1 reference

Comparing antibody and small-molecule therapies for cancer

12 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

New challenges to medicare beneficiary access to mAbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Upping the ante on antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

PRL PTPs: mediators and markers of cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

PRL-3 phosphatase and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Polyoma virus middle T antigen and its role in identifying cancer-related molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

A phosphatase associated with metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Protein tyrosine phosphatases in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

PRL-3: a phosphatase for metastasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Breast cancer metastasis: markers and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Mechanisms of regulated unconventional protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Current perspectives on HER2 testing: a review of national testing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002296

10.1126/SCITRANSLMED.3002296

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference